Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-17 Sale | 2023-01-19 8:42 pm | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $119 | $595,000 | 127,851 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 8:39 pm | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman President & CEO | 25,000 | $118.99 | $2,974,750 | 388,777 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-18 4:43 pm | Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 375,000 | $19 | $7,125,000 | 2,223,022 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-17 7:47 pm | Prometheus Biosciences Inc. | RXDX | Point72 Biotech Private Investments LLC Differentiated Ventures Investments LLC 72 Investment Holdings LLC COHEN STEVEN A/SAC CAPITAL MGMT LP Former 10% Owner | 800,000 | $19 | $15,200,000 | 2,648,024 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-16 9:49 pm | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 14,000 | $19 | $266,000 | 14,000 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-16 9:48 pm | Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director | 15,000 | $19 | $285,000 | 15,000 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-16 9:47 pm | Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director | 500 | $19 | $9,500 | 500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-17 Exercise | 2023-01-19 8:42 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $0 | 127,851 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 8:42 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $3.7 | 127,851 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 8:39 pm | N/A 2029-11-06 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman President & CEO | 25,000 | $0 | 388,777 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 8:39 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman President & CEO | 25,000 | $2.9 | 388,777 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 8:19 pm | N/A 2032-12-15 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 12,920 | $0 | 12,920 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 8:38 pm | N/A 2032-12-08 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 43,896 | $0 | 60,527 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 8:35 pm | N/A 2032-12-08 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 43,896 | $0 | 43,896 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 8:32 pm | N/A 2032-12-08 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman President & CEO | 166,043 | $0 | 184,074 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:30 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:28 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Swain Judith L Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:26 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director | 22,551 | $0 | 22,551 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:24 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Laur James Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:22 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Hendrix Martin Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:20 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 21,013 | $0 | 21,013 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:18 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director | 21,526 | $0 | 21,526 (Direct) | View |
| 2022-05-20 Option Award | 2022-05-20 7:15 pm | 2025-05-20 2032-05-19 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 86,582 | $0 | 86,582 (Direct) | View |
| 2022-05-20 Option Award | 2022-05-20 7:13 pm | 2025-05-20 2032-05-19 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 86,582 | $0 | 86,582 (Direct) | View |
| 2022-05-20 Option Award | 2022-05-20 7:11 pm | 2025-05-20 2032-05-19 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman President & CEO | 246,639 | $0 | 246,639 (Direct) | View |
| 2022-04-05 Other | 2022-04-05 5:49 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Cedars Sinai Intellectual Property Co 10% Owner | 142,376 | $0 | 5,008,508 (Indirect) | View |
| 2021-12-01 Exercise | 2021-12-03 7:02 pm | N/A 2029-11-06 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman President & CEO | 15,400 | $0 | 137,931 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 7:02 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman President & CEO | 15,400 | $2.9 | 137,931 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:19 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 541 | $0 | 541 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:17 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director | 1,083 | $0 | 1,083 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:15 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director | 2,165 | $0 | 2,165 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:12 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Andrews Timothy K. General Counsel | 54,132 | $0 | 54,132 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:10 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 70,371 | $0 | 70,371 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:08 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 102,155 | $0 | 102,155 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:06 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Luo Allison Chief Medical Officer | 113,677 | $0 | 113,677 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:03 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman President & CEO | 290,000 | $0 | 290,000 (Direct) | View |
| 2021-09-08 Option Award | 2021-09-15 8:09 pm | N/A 2031-09-07 | Prometheus Biosciences Inc. | RXDX | Luo Allison Chief Medical Officer | 4,500 | $0 | 4,500 (Indirect) | View |
| 2021-06-25 Ownership | 2021-06-25 6:03 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Cedars Sinai Intellectual Property Co 10% Owner | 0 | $0 | 5,008,508 (Indirect) | View |
| 2021-05-14 Option Award | 2021-05-17 7:24 pm | N/A 2031-05-13 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-04-14 Option Award | 2021-04-16 6:46 pm | N/A 2031-04-13 | Prometheus Biosciences Inc. | RXDX | Laur James Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-04-14 Option Award | 2021-04-16 6:40 pm | N/A 2031-04-13 | Prometheus Biosciences Inc. | RXDX | Hendrix Martin Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-03-16 Conversion | 2021-03-18 4:43 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 3,696,045 | $0 | 2,223,022 (Indirect) | View |
| 2021-03-11(A) Ownership | 2021-03-18 4:41 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 0 | $0 | 1,848,022 (Indirect) | View |
| 2021-03-16 Conversion | 2021-03-17 7:47 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Point72 Biotech Private Investments LLC Differentiated Ventures Investments LLC 72 Investment Holdings LLC COHEN STEVEN A/SAC CAPITAL MGMT LP Former 10% Owner | 20,328,269 | $0 | 2,648,024 (Indirect) | View |
| 2021-03-16 Conversion | 2021-03-16 9:53 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | CEDARS SINAI MEDICAL CENTER 10% Owner | 48,576,089 | $0 | 5,008,508 (Direct) | View |
| 2021-03-16 Conversion | 2021-03-16 9:51 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Yamada Tadataka and Chairman of the Board | 146,667 | $0 | 13,333 (Direct) | View |